1 |
Le TT, McGrath SR, Fasinu PS. Herb-drug Interactions in Neuropsychiatric Pharmacotherapy - A Review of Clinically Relevant Findings. Curr Neuropharmacol 2022;20:1736-51. [PMID: 34370637 DOI: 10.2174/1570159X19666210809100357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
2 |
Rao P, McCullough MF, Stevens J, Edwardson MA. Grief-induced reversible cerebral vasoconstriction syndrome (RCVS). BMJ Case Rep 2020;13:e232204. [PMID: 31996381 DOI: 10.1136/bcr-2019-232204] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
3 |
Chalhoub NE, Hernandez DA. A 29-Year-Old Woman With Acute Respiratory Failure and Eosinophilic Lung Disease. Am J Ther 2017;24:e488. [PMID: 27574938 DOI: 10.1097/MJT.0000000000000484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
4 |
Kinsella LJ, Grossberg GT, Prakash N. Drug-Dietary Interactions: Over-the-Counter Medications, Herbs, and Dietary Supplements. Clinical Psychopharmacology for Neurologists 2018. [DOI: 10.1007/978-3-319-74604-3_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
5 |
Costa I, Mendonça MD, Cruz e Silva V, Calado S, Viana-baptista M. Herbal Supplements Association with Reversible Cerebral Vasoconstriction Syndrome: A Case Report. Journal of Stroke and Cerebrovascular Diseases 2017;26:673-6. [DOI: 10.1016/j.jstrokecerebrovasdis.2016.11.125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
6 |
Piantadosi C, Bove L, Minnetti M, Brogi M. Severe reversible cerebral vasoconstriction syndrome after taking a product for slimming. Neurol Sci 2016;37:2031-3. [DOI: 10.1007/s10072-016-2688-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
7 |
Santos L, Azevedo E. Reversible cerebral vasoconstriction syndrome - A narrative revision of the literature. Porto Biomed J 2016;1:65-71. [PMID: 32258552 DOI: 10.1016/j.pbj.2016.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
8 |
Raven ML, Ringeisen AL, McAllister AR, Knoch DW. Reversible Cerebral Vasoconstriction Syndrome Presenting With Visual Field Defects. J Neuroophthalmol 2016;36:187-90. [PMID: 26807800 DOI: 10.1097/WNO.0000000000000339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
9 |
Gurley BJ, Steelman SC, Thomas SL. Multi-ingredient, Caffeine-containing Dietary Supplements: History, Safety, and Efficacy. Clinical Therapeutics 2015;37:275-301. [DOI: 10.1016/j.clinthera.2014.08.012] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 6.6] [Reference Citation Analysis]
|
10 |
Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course. AJNR Am J Neuroradiol 2015;36:1392-9. [PMID: 25593203 DOI: 10.3174/ajnr.A4214] [Cited by in Crossref: 149] [Cited by in F6Publishing: 154] [Article Influence: 18.6] [Reference Citation Analysis]
|
11 |
Narasimha A, Shetty PH, Nanjundaswamy MH, Viswanath B, Bada Math S. Hydroxycut - Dietary supplements for weight loss: Can they induce mania? Aust N Z J Psychiatry 2013;47:1205-6. [PMID: 23761572 DOI: 10.1177/0004867413493522] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
12 |
Skandhan AK, Ramakrishnan KG, Anand R. Call-Fleming syndrome. Indian J Radiol Imaging 2013;23:198-201. [PMID: 24347846 DOI: 10.4103/0971-3026.120258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
13 |
Sherid M, Samo S, Sulaiman S, Gaziano JH. Ischemic colitis induced by the newly reformulated multicomponent weight-loss supplement Hydroxycut®. World J Gastrointest Endosc 2013; 5(4): 180-185 [PMID: 23596542 DOI: 10.4253/wjge.v5.i4.180] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
14 |
Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012;11:906-17. [PMID: 22995694 DOI: 10.1016/S1474-4422(12)70135-7] [Cited by in Crossref: 519] [Cited by in F6Publishing: 527] [Article Influence: 47.2] [Reference Citation Analysis]
|